FDA Advises Covid-19 Vaccine Makers to Tackle JN.1 Variant | Morningstar

Retrieved on: 2024-06-07 22:03:57

Tags for this article:

Click the tags to see associated articles and topics

FDA Advises Covid-19 Vaccine Makers to Tackle JN.1 Variant | Morningstar. View article details on hiswai:

Excerpt

By Sabela Ojea. The Food and Drug Administration has recommended that manufacturers of Covid-19 vaccines should focus on the JN.1 variant ...

Article found on: www.morningstar.com